Evidence map›Paper›PMID 30091033›Full record

ArticleInflammation2018

Antibody Cross-Linking of CD14 Activates MerTK and Promotes Human Macrophage Clearance of Apoptotic Neutrophils: the Dual Role of CD14 at the Crossroads Between M1 and M2c Polarization.

Gaetano Zizzo, Philip L Cohen

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammation, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Immune aging and infectious diseases.Chinese medical journal · 2024
    Review
  8. Article
  9. The Role of TAM Receptors in Bone.International journal of molecular sciences · 2023
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Gaetano ZizzoTemple Autoimmunity Center, Temple University, 3500 N. Broad Street, Philadelphia, PA, 19140, USA. gaetano.zizzo@hotmail.it.
Philip L CohenTemple Autoimmunity Center, Temple University, 3500 N. Broad Street, Philadelphia, PA, 19140, USA. philco@temple.edu.
Temple University · US

Funding

Regulation of Immunity and Autoreactivity by the Mer Receptor Kinase SubfamilyU19AI082726 · NIAID · THOMAS JEFFERSON UNIVERSITY · PI ROSTAMI, A.M. · 2009 to 2013
$2.9M
National Institute of Allergy and Infectious Diseases 5U19AI082726
6 · The paper itself

Abstract

Mer receptor tyrosine kinase (MerTK) is key for efficient phagocytosis of apoptotic neutrophils (ANs) and homeostasis of IL-10 production by human anti-inflammatory M2c monocytes/macrophages. We asked whether stimulation of M2c surface receptors contributes in turn to MerTK activation. For this purpose, human monocytes/macrophages were differentiated under M1, M2a, and M2c polarizing conditions. The effects of antibody-mediated cross-linking of M2c receptors (i.e., CD14, CD16, CD32, CD163, CD204) on MerTK phosphorylation and phagocytosis of ANs were tested. MerTK expression was also studied by flow cytometry and western blot in the presence of LPS and in M2c-derived microvesicles (MVs). Antibody cross-linking of either CD14 or CD32/FcγRII led to Syk activation and MerTK phosphorylation in its two distinct glycoforms (175-205 and 135-155 kDa). Cross-linked CD14 enhanced efferocytosis by M2c macrophages and enabled M1 and M2a cells to clear ANs efficiently. In M1 conditions, LPS abolished surface MerTK expression on CD14

Indexed as

PhagocytosisAntibodiesCell Differentiationc-Mer Tyrosine KinaseHumansLipopolysaccharide ReceptorsLipopolysaccharidesMacrophagesMicrovesselsNeutrophilsReceptors, IgGAntibodiesc-Mer Tyrosine KinaseLipopolysaccharide ReceptorsLipopolysaccharidesMERTK protein, humanReceptors, IgGapoptotic neutrophils (ANs)CD14CD32 (FcγRII)human macrophagesMer receptor tyrosine kinase (MerTK)microvesicles (MVs)

Identifiers

PMID30091033
OpenAlexW2886297091

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.